F-14413

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameF-14413
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 inverse agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPierre Fabre Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A